What is the appropriate baclofen dosing for treating hiccups in a patient with a left middle cerebral artery (MCA) territory infarct and acute decompensated heart failure?

Baclofen Dosing for Hiccups in Left MCA Infarct with Acute Decompensated Heart Failure

Start baclofen at 10 mg orally three times daily for persistent hiccups in this stroke patient, with careful monitoring for sedation and hypotension given the concurrent acute decompensated heart failure.

Rationale for Baclofen Use

The evidence specifically supports baclofen for stroke-related hiccups. In a randomized controlled trial of 30 stroke patients with persistent hiccups, baclofen 10 mg three times daily for 5 days was significantly more effective than placebo (relative risk 7.00,95% CI 1.91-25.62, P = 0.003) 1. This is the most direct evidence for your clinical scenario.

A case report specifically documented successful treatment of persistent hiccups from right MCA infarction involving the insula using a combination of perampanel and baclofen, though baclofen alone was partially effective 2. The insula involvement is particularly relevant as it can impair respiratory reflexes and cause hiccups through respiratory reflex disinhibition.

Specific Dosing Protocol

Per FDA labeling, the standard titration schedule is 3:

• Start: 5 mg three times daily for 3 days
• Increase to 10 mg three times daily for 3 days (this is where most stroke patients in trials remained)
• Further increases to 15 mg or 20 mg three times daily only if needed
• Maximum: 80 mg daily (20 mg four times daily)

However, for hiccups specifically in stroke patients, the evidence supports starting directly at 10 mg three times daily 1, which is reasonable given the symptomatic burden and the need for rapid relief.

Critical Safety Considerations in This Patient

Acute Decompensated Heart Failure Concerns

This patient's acute decompensated heart failure creates specific risks:

• Sedation risk: Baclofen causes CNS depression 3. In a patient with heart failure who may already have reduced cerebral perfusion, monitor closely for excessive drowsiness (occurred in 1 patient in the stroke trial 1)

• Hypotension monitoring: While not a direct cardiovascular depressant, baclofen's sedative effects combined with heart failure medications (ACE inhibitors, diuretics, beta-blockers per guidelines 4, 5) could compound hypotension

• Renal function: The heart failure guidelines emphasize monitoring renal function closely 4, 6. Baclofen dosing should be adjusted if creatinine clearance is impaired, though specific adjustments aren't detailed in the label 3

Stroke-Specific Monitoring

• Seizure threshold: Baclofen requires EEG monitoring in epilepsy patients as it can worsen seizure control 3. While your patient has an MCA infarct (seizure risk ~5-12% in acute ischemic stroke 7), prophylactic antiseizure medication is not recommended unless seizures are documented

• Avoid abrupt discontinuation: The FDA label warns about withdrawal symptoms 3. Taper slowly if discontinuing

Practical Implementation Algorithm

1. Confirm hiccups are persistent (>48 hours) - baclofen appears more effective for chronic hiccups (OR 0.51 for benefit in acute vs chronic, p=0.02) 8

2. Check baseline: Blood pressure, renal function, mental status

3. Start 10 mg orally three times daily (can use 5 mg TID if very concerned about sedation)

4. Monitor daily:

   • Blood pressure (maintain SBP >90-100 mmHg per heart failure guidelines 6)
   • Mental status/sedation level
   • Hiccup frequency and severity
   • Renal function if heart failure worsening

5. Assess response at 3-5 days:

   • If resolved: continue for total 5-7 days, then taper
   • If partial response: increase to 15 mg TID
   • If no response: consider alternative diagnosis or combination therapy

6. If ineffective after 7-10 days at adequate doses, consider adding chlorpromazine (though this has more cardiovascular side effects) or consulting neurology for alternative agents like perampanel 2

Common Pitfalls to Avoid

• Don't use beta-blockers or calcium channel blockers acutely in frank heart failure with pulmonary congestion 6 - but this doesn't contraindicate baclofen
• Don't assume hiccups are benign - they can impair oral intake, sleep, and rehabilitation in stroke patients 7
• Don't stop baclofen abruptly - taper over 1-2 weeks to avoid withdrawal 3
• Don't ignore alternative causes - ensure no gastric distention, metabolic abnormalities, or medication effects (though dopamine agonists are more commonly implicated 9)

Expected Outcomes

Based on the stroke trial, complete cessation of hiccups occurred in 93% of baclofen-treated patients vs 13% with placebo 1. However, a larger mixed-methods study showed only 35% overall palliation 8, suggesting real-world effectiveness may be lower, particularly emphasizing the importance of the >48-hour duration criterion.

Adverse events are generally mild - drowsiness and dizziness being most common - with no serious adverse events documented in the stroke-specific trial 1.